GV (Google Ventures)

Activity from announced rounds

Activity in this selectionJan 31, 2026 · Jan 1, 2026

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
6
Confirmed lead rounds
—
6 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$1.4B
6 disclosed · full round size, not this investor’s share

By stage

Series C+3
Seed1
Series A1
Series B1

By primary sector

Biotech3
AI2
Healthtech1

By country

United States5
United Kingdom1

Rounds

6 in this selection
Synthesia

Develops AI-powered digital avatars for corporate clients

$200MSeries E
Role not disclosed
OpenEvidence

Provides AI-powered medical search engine for clinicians

$250MSeries D
Role not disclosed
Humans&

Provides AI software to help people collaborate with each other

$480MSeed
Role not disclosed
EpiBiologics

Develops bispecific antibodies for targeted degradation of extracellular proteins.

$107MSeries B
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed
Prudentia Sciences

Provides AI-native due diligence for life sciences dealmaking

$20MSeries A
Role not disclosed